What will be the impact of human papillomavirus (HPV) vaccination on HPV-associated cancers in Switzerland? A mathematical modelling study
Start/End: 01.02.2015 – 31.08.2017
Approved amount: 261’900 CHF (~ 258k USD)
Applicant(s): Christian L. Althaus, Nicola Low, Mirjam Kretzschmar, Johannes Bogaards, Matthias Egger, Sandro Gsteiger
This project aims to determine how many future cases and deaths from cancer in Switzerland could be prevented by HPV vaccination. We aim to improve on previous projections by using data sources that are specific to Switzerland, wherever possible. This includes using data about actual vaccine uptake in different cantons. We will also investigate whether current vaccination patterns provide value for money and how cost-effectiveness could be improved.
- Riesen M, Garcia V, Low N, Althaus CL. (2017) Modeling the consequences of regional heterogeneity in human papillomavirus (HPV) vaccination uptake on transmission in Switzerland. Vaccine, 35:7312-7321.
- Riesen M, Konstantinoudis G, Lang P, Low N, Hatz C, Maeusezahl M, Spaar A, Bühlmann M, Spycher B, Althaus CL. (2017)
Exploring variation in human papillomavirus vaccination uptake: multi-level spatial analysis. bioRxiv, 210260.